Nantahala Capital Management’s TuHURA Biosciences, Inc. Common Stock HURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,279
| Closed | -$15.6K | – | 139 |
|
|
2024
Q3 | $15.6K | Buy |
+2,279
| New | +$15.6K | ﹤0.01% | 122 |
|
|
2024
Q2 | – | Sell |
-365
| Closed | -$1.29K | – | 134 |
|
|
2024
Q1 | $1.29K | Sell |
365
-264
| -42% | -$929 | ﹤0.01% | 111 |
|
|
2023
Q4 | $3.74K | Sell |
629
-17
| -3% | -$101 | ﹤0.01% | 111 |
|
|
2023
Q3 | $91.4K | Buy |
+646
| New | +$91.4K | 0.01% | 106 |
|
|
2023
Q1 | – | Sell |
-340
| Closed | -$82K | – | 122 |
|
|
2022
Q4 | $82K | Hold |
340
| – | – | 0.01% | 98 |
|
|
2022
Q3 | $64K | Buy |
340
+274
| +415% | +$51.6K | ﹤0.01% | 96 |
|
|
2022
Q2 | $32K | Sell |
66
-313
| -83% | -$152K | ﹤0.01% | 101 |
|
|
2022
Q1 | $264K | Hold |
379
| – | – | 0.01% | 96 |
|
|
2021
Q4 | $338K | Hold |
379
| – | – | 0.01% | 101 |
|
|
2021
Q3 | $582K | Buy |
379
+80
| +27% | +$123K | 0.02% | 97 |
|
|
2021
Q2 | $1.19M | Sell |
299
-217
| -42% | -$862K | 0.03% | 89 |
|
|
2021
Q1 | $1.57M | Buy |
516
+360
| +231% | +$1.1M | 0.05% | 89 |
|
|
2020
Q4 | $349K | Buy |
+156
| New | +$349K | 0.01% | 100 |
|